Skip to main content

Table 4 Relative efficacy of Trichoderma parent and mutant isolates on percent recovery of lesion size

From: Evaluation of the bioformulation of potent native strains of Trichoderma spp. against the foot rot/gummosis of Kinnow mandarin

Isolates Recovery of lesion size (%)
2016–2017 2017–2018 Total percent recovery
T2 Parent 17.82 (24.94) 26.46 (30.27) 44.28 (41.60)
T2 Mutant 24.83 (29.30) 27.17 (31.35) 52.00 (46.11)
T3 Parent 18.07 (24.46) 27.30 (31.23) 45.37 (42.31)
T3 Mutant 25.84 (29.70) 30.13 (33.08) 55.97 (48.63)
T4 Parent 25.24 (30.10) 30.41 (33.25) 55.65 (48.30)
T4 Mutant 30.97 (33.76) 40.29 (39.30) 71.26 (57.75)
T16 Parent 31.45 (34.04) 34.36 (35.70) 65.82 (54.28)
T16 Mutant 36.71 37.21 46.10 (42.67) 82.80 (68.44)
T20 Parent 36.18 (36.95) 43.51 (41.21) 79.69 (63.37)
T20 Mutant 44.45 (41.79) 51.38 (45.77) 95.67 (75.81)
T21 Parent 18.16 (23.62) 21.63 (27.46) 39.79 (38.87)
T21 Mutant 24.07 (28.73) 26.71 (31.35) 50.79 (45.43)
T25 Parent 20.77 (26.93) 27.97 (31.84) 48.74 (44.26)
T25 Mutant 26.87 (31.01) 32.85 (34.74) 59.71 (50.68)
T.viride* 27.29 (41.47) 29.31 (31.98) 56.60 (48.86)
T.harzianum* 17.98 (25.07) 20.07 (26.59) 38.05 (38.04)
Metalaxyl-M+Mancozeb* 35.44 (36.43) 37.35 (37.63) 72.80 (58.78)
Control (-)16.50 (23.64) (-)23.41 (23.40) (-)39.91 (39.11)
CD (p ≤ 0.05) 10.29 8.90 11.66
  1. T2, T3, T4, T16, T20 and T21 = T. asperellum, T25 = T. harzianum
  2. *Standard checks
  3. Figures in parenthesis is arc sine transformation